Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Real-world outcomes for multiple myeloma patients after apheresis for planned chimeric antigen receptor T-cell therapy

The outcomes of all RRMM patients who underwent T-cell apheresis for planned CAR-T therapy are described, to characterise the apheresis-to-infusion interval and the reasons for, and correlates of, failure to reach infusion, and to report progression-free survival (PFS) and overall survival (OS) anchored at the date of...

Ayrton I. Bangolo, Sarvarinder K. Gill, Li-Li Zhang et al. · 0 citations
Open access Oct 2026

Healthcare resource utilization and costs of US patients with small cell lung cancer treated with second-line therapies: a retrospective real-world database study.

AIMS To examine all-cause and myelosuppressive event (MYSPE)-related healthcare resource utilization and costs among patients with small cell lung cancer (SCLC) in the United States treated with second-line therapies. MATERIALS AND METHODS This retrospective cohort study of the Optum Market Clarity database included...

X. Fan, A. Nguyen, B. Rengarajan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.